High PSALow volume diseaseRarely, patients with prostate cancer (PC) present with Prostate-Specific Antigen (PSA) scores >20ng/mL but otherwise very low-risk disease. Oncologists debate whether malignancies in these patients behave more comparably to low-risk or high-risk disease. Our objective ...
Prostate-specific antigen (PSA) is the tumor marker most widely used in conjunction with digital rectal examination (DRE) for the early detection of prostate cancer (PCa). Due to its limitations, especially the high rate of false positive (FP) results, PSA screening of transplant candidates is...
Prostate-specific antigen (PSA) is the tumor marker most widely used in conjunction with digital rectal examination (DRE) for the early detection of prostate cancer (PCa). Due to its limitations, especially the high rate of false positive (FP) results, PSA screening of transplant candidates is...
Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: A study on 546 patients The aim of this study was to analyse the factors that predict the diagnosis of prostate cancer (PCa) after high-grade prostatic intraepithelial neoplasia (... A Antonelli...
underuse for high-risk prostate cancer remains substantial. Several factors affect the utility of initial diagnostic imaging, including the variable definition of high-risk prostate cancer, variable guideline recommendations, poor accuracy of existing imaging tests, and the difficulty in validating imaging...
Beyond safety and anti-tumor activity based on PSA dropping to undetectable levels, investigators also looked for changes in the tumor microenvironment before and after enoblituzumab treatment. They found increased markers of cytotoxicity after treatment, consistent with the concept that the immune syst...
All men with a PSA below 3ng/ml at baseline are reinvited 4 years later. Whether this somewhat ... M Randazzo,D Seiler,J Beatrice,... - 《Journal of Urology》 被引量: 2发表: 2013年 Social disparities and prostate cancer: mapping the gaps in our knowledge. and which neglected.The ...
2 The study’s eligible patients had clinically localized prostate cancer with clinical T1c to T3b disease that would be classified as intermediate or high risk by NCCN, with a PSA level less than 100 ng/mL. Men were randomized to receive 4 or 28 months of ADT. The minimum allowable ...
b. Distributions of age (n = 125) and plasma PSA (n = 117) levels of patients in our cohort. For the boxplot, center line indicates the median value, lower and upper hinges represent the 25th and 75th percentiles, respectively and whiskers denote 1.5 × interquartile range. c....
Diagram of Study Cohort View LargeDownload M1 indicates bone metastases; NCCN, National Comprehensive Cancer Network; PSA, prostate-specific antigen. Figure 2. Overall Survival of Patients Treated at High vs Low Average Cumulative Facility Radiation Volume Centers View LargeDownload Unadjusted (A) and ...